
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About
Gyrodyne Company of America Inc (GYRO)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: GYRO (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit -100% | Avg. Invested days 13 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 18.19M USD | Price to earnings Ratio 45.94 | 1Y Target Price - |
Price to earnings Ratio 45.94 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.36 | 52 Weeks Range 6.80 - 11.96 | Updated Date 06/29/2025 |
52 Weeks Range 6.80 - 11.96 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.18 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -137.05% | Operating Margin (TTM) -121.3% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE 45.94 | Forward PE - | Enterprise Value 12400998 | Price to Sales(TTM) 6.64 |
Enterprise Value 12400998 | Price to Sales(TTM) 6.64 | ||
Enterprise Value to Revenue 2.59 | Enterprise Value to EBITDA -8.07 | Shares Outstanding 2199310 | Shares Floating 662432 |
Shares Outstanding 2199310 | Shares Floating 662432 | ||
Percent Insiders 31.95 | Percent Institutions 36.97 |
Upturn AI SWOT
Gyrodyne Company of America Inc
Company Overview
History and Background
Gyrodyne Company of America Inc. was founded in 1946, initially focusing on rotary-wing aircraft. Over time, it shifted its primary business to real estate development and management, particularly medical office properties.
Core Business Areas
- Real Estate Operations: The primary business is the ownership, lease, and management of income-producing properties, mainly medical office buildings leased to physicians and medical-related tenants.
Leadership and Structure
Gyrodyne's leadership consists of a board of directors and executive management team. The company structure reflects its focus on real estate management and investment.
Top Products and Market Share
Key Offerings
- Medical Office Space: Gyrodyne's core offering is medical office space. Market share data is difficult to specify as this is a local business and data is limited, but Gyrodyne owns property in New York and other key areas. Competitors are other real estate investment trusts (REITs) and private landlords.
Market Dynamics
Industry Overview
The medical office building (MOB) market is driven by an aging population and increasing demand for outpatient healthcare services. It's characterized by stable occupancy rates and rental growth.
Positioning
Gyrodyne is a smaller player in the medical office building market, focusing on select properties and long-term leases with medical professionals. Competitive advantage may come from specializing in medical spaces and geographic location.
Total Addressable Market (TAM)
The US medical office building market is estimated at hundreds of billions of dollars. Gyrodyne's is positioned as a small player in a specialized market.
Upturn SWOT Analysis
Strengths
- Stable revenue from long-term leases
- Specialization in medical office space
- Geographic concentration in high-demand areas (historically)
- Relatively stable, low-risk business model
Weaknesses
- Limited scale compared to larger REITs
- Concentration risk in geographic area.
- Dependence on healthcare industry trends
- Lack of diversification
Opportunities
- Acquisition of additional medical office properties
- Expansion into new geographic markets
- Development of new medical office buildings
- Increase rental rates in existing properties
Threats
- Economic downturn affecting healthcare spending
- Increased competition from larger REITs
- Changes in healthcare regulations
- Rising interest rates affecting property values
Competitors and Market Share
Key Competitors
- DOC
- HR
- WELL
- OHI
Competitive Landscape
Gyrodyne is a relatively small player compared to publicly traded REITs like Welltower (WELL) or Healthpeak Properties (DOC). It likely competes on a local or regional level, emphasizing personalized service and specialized medical office spaces. Bigger competitors have greater access to capital and a more diversified portfolio.
Growth Trajectory and Initiatives
Historical Growth: Requires financial data. As a real estate company, growth would be tied to property acquisitions and rental income.
Future Projections: Requires financial data and analyst estimates
Recent Initiatives: Recent initiatives would relate to property acquisitions, lease renewals, or property improvements. Requires further data and research.
Summary
Gyrodyne Company of America is a small real estate company specializing in medical office properties. Its stable revenue from long-term leases and specialization in the healthcare sector are strengths. However, its limited scale and geographic concentration pose challenges, with competition from larger REITs.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Publicly available information, including company websites, press releases, and industry reports. Limited access to private financials.
- Company Filings
- Industry Analysis Reports
Disclaimers:
This analysis is based on publicly available information and may not be entirely accurate due to limited data access. The AI-based rating is an estimate and should not be considered investment advice. Investment decisions should be based on thorough research and consultation with a financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Gyrodyne Company of America Inc
Exchange NASDAQ | Headquaters Saint James, NY, United States | ||
IPO Launch date 1995-08-18 | President, CEO, CFO & Treasurer Mr. Gary Jay Fitlin | ||
Sector Real Estate | Industry Real Estate Services | Full time employees 6 | Website https://www.gyrodyne.com |
Full time employees 6 | Website https://www.gyrodyne.com |
Gyrodyne, LLC (the "Company") owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. The Company owns a 63-acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York, both of which are the subject of plans to seek value-enhancing entitlements. The Company's common shares are traded on the NASDAQ Capital Market under the symbol GYRO.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.